I Used to Grow Brain Tumors in a Lab. Now I Think About Databases.

There's a particular smell in a research hospital corridor at 6 a.m. Antiseptic, coffee, and something indefinably alive. It's a smell you can't forget. For years, I spent time in that corridor, pipette in hand, scheduling my entire life around when my cells needed feeding, while also writing R scripts to make sense of the health data those same cells were generating.

That combination started earlier than most people would expect. While still in high school I was doing biological research alongside computational work, and the two were never really separate for me. I wasn't choosing between being a scientist and a data person working in data analytics. I was doing both, because the science kept demanding it, especially as biological research began to resemble big data problems more than traditional lab work..

At Barrow Neurological Institute, the research center was attached to a hospital - patient tumors were sent to us researchers post-operation. We'd culture those cells and use them in experiments; the science was incredible and fascinating. It felt alive and curious. The data infrastructure sitting underneath all of it? That was a different story.

Eventually, I left the bench, but I never stopped thinking about what I'd seen in those labs. When I think about legacy systems and compliance bottlenecks, I think about them through the lens of biological research - referring to challenges I faced at an actual bench.

"Sometimes I had to wait 24 hours for a result turnaround. In finance or high-tech, people won't tolerate 15 minutes. That gap right there tells you everything about where healthcare's data management infrastructure stands today."

The Lab Reveals What No IT Audit Will: Healthcare Organizations Have a Data Silo Problem

Biological and clinical research is full of brilliant people: cell biologists, genomicists, oncologists who have spent their careers mastering extraordinarily complex domains. What they are not is data engineers.

As someone concurrently studying computer science, I lived at that intersection. The subject matter experts around me understood biology deeply. What they struggled with was the data layer sitting underneath it - and honestly, they shouldn't have had to think about it at all.

Here's what that gap looks like in practice: the tools of modern biology - RNA sequencing platforms, proteomics pipelines, imaging systems - generate enormous amounts of heterogeneous health data. You're dealing with structured data like lab values and vital signs, semi-structured data from instrument outputs, unstructured data like physician notes and imaging reports, and high-volume genomic sequences all at once, creating challenges that increasingly resemble big data environments. Connecting these datasets to a platform that can handle them at scale - something closer to a genuine clinical data platform - takes specialized skills in data analytics that most subject matter experts don't have and shouldn't need to develop.

The result is a secondary data problem that grows alongside the actual science problem. Researchers end up spending real time on questions like: how do I get this into a format I can work with? How do I ingest data without corrupting it? How do I query across outputs from three different instruments?

The biology becomes secondary to data plumbing. That's not good for science - and worse for the patients on the other side of it.

Why Healthcare's Data Management Problem Keeps Getting Harder to Solve

The Legacy System Trap

Most clinical data management infrastructure in the US was built in the 1990s and early 2000s. Hospitals and research institutions brought in electronic health records (EHR)  systems, lab information platforms, radiology systems - none architected for EHR data integration or interoperability across the broader clinical environment. They got bolted together over decades, expanded across entire institutional landscapes, and became so embedded that replacing them stopped feeling like a real option.

After working within that infrastructure for years, I understand what it feels like to wait 24 hours for an experimental result. It's not always the biology that's slow - sometimes the batch processing pipeline requires it. In most industries that's unheard of, but in healthcare and life sciences it can be the norm. You just plan around it.

The Cost of Staying Compliant

The systems used  to manage health data in healthcare aren't being maintained because they're good - they're being maintained because they're known.

HIPAA compliance is genuinely expensive and very risky: compliance audits, security reviews, validation processes. Industry-wide costs now run into the billions annually. The average healthcare data breach costs $7.42 million - the highest of any industry. So the calculation for IT decision-makers becomes pretty straightforward: is it less risky to keep the old system we know is compliant, or to migrate to something new and introduce unknowns? Most institutions keep landing in the same place. Keep the old system. Patch it. Add to it. Keep it running somehow.

It's like putting lipstick on a pig, and it's not sustainable. The downstream effect is a healthcare system where most analytics still runs on overnight batch cycles, real-time clinical analytics is largely aspirational, and teams are paying for redundant storage across dozens of siloed platforms. Without a proper healthcare data management platform underneath it all, you can't even see the problem clearly, let alone fix it. Poor data quality - often driven by fragmented and siloed systems - is estimated to cost the U.S. healthcare system up to $3.1 trillion annually, reflecting widespread inefficiencies, duplication, and gaps in care.

"It is easier to maintain a system you already have that you know is compliance-ready than to migrate to something new. I am dealing with these legacy systems. They might not work the best, but there is more perceived risk in replacing them than just dealing with them as they are."

What Real-Time Healthcare Analytics Actually Means When Lives Are at Stake

When most people in the data space refer to real-time processing they mean performance in terms of milliseconds versus seconds. In healthcare analytics, the stakes are categorically different.

A real-time sepsis alert means a clinician finds out before a patient is in critical condition. A real-time adverse event flag in a clinical trial means a dangerous drug interaction gets caught before it affects more participants.

The data infrastructure determines whether any of this detection is actually possible. A system built on nightly batch cycles, spread across platforms with no unified query layer, cannot support those things. I saw this firsthand. When your turnaround is measured in hours or days, the real-time promise of modern medicine stays aspirational.

For healthcare IT leaders evaluating platforms: this is the gap worth measuring. Not just query speed on a benchmark - but whether the architecture can eliminate the batch cycle entirely, and deliver analytics at the point of care rather than the morning after.

The Case for a Unified Healthcare Analytics Platform - Not More Point Solutions

Healthcare/life sciences data infrastructure needs consolidation: one platform that can handle structured, unstructured, and semi-structured health data across all facets of patient care, research, and adjacent systems like insurance and billing. It needs real-time ingestion that keeps pace with data as it's generated. The field needs a low-latency, HIPAA-compliant database where streaming analytics and operational analytics run on the same system - one that doesn't need to be retrofitted to fit specific use cases or legacy environments.

I've had the chance to see how this plays out across industries since leaving the lab. Different domains with totally different technical problems have the same underlying pattern every time: brittle data infrastructure prevents people from solving actual problems.

In healthcare, those problems are tied to human lives. When I think about what would have actually changed my time at the bench, a real-time analytics platform would have. A system where a 48-hour batch cycle wasn't just the accepted price of a single result. Where the infrastructure matched the urgency of the science.

The science in healthcare has always been extraordinary. The infrastructure just needs to catch up.